Skip to Main Content

Author Details

Peter J Mullen
University of St Andrews
2010
21
17
PMIDPaper TitleJournal TitlePublished Year
37000221The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent.Cancer Chemother Pharmacol2023
36411320Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells.Nat Cancer2022
33609439Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth.Cell Metab2021
33767183SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition.Nat Commun2021
32203069A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer.Prostate Cancer Prostatic Dis2020
31023626An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer.Mol Metab2019
29229608Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins.Cancer Res2018
30197082Extracellular Matrix Remodeling Regulates Glucose Metabolism through TXNIP Destabilization.Cell2018
30300580MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis.Cancer Cell2018
25300705Simvastatin induces mitochondrial dysfunction and increased atrogin-1 expression in H9c2 cardiomyocytes and mice in vivo.Arch Toxicol2016
27562463The interplay between cell signalling and the mevalonate pathway in cancer.Nat Rev Cancer2016
25631767AML cells have low spare reserve capacity in their respiratory chain that renders them susceptible to oxidative metabolic stress.Blood2015
26353928Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death.Oncotarget2015
24337703Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells.Breast Cancer Res Treat2014
24994712Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop.Cancer Res2014
24656129Largen: a molecular regulator of mammalian cell size control.Mol Cell2014
24030976MYC phosphorylation at novel regulatory regions suppresses transforming activity.Cancer Res2013
22743351Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans.Ther Drug Monit2012
21354273Matrix metalloproteinases 2 and 9 in the cochlea: expression and activity after aminoglycoside exposition.Neuroscience2011
21839782Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt.Biochim Biophys Acta2011
20018177Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy.Biochem Pharmacol2010
  • 1 - 21 of 21

Recommended Authors

The Rockefeller University
Career Start Year 2016
Number of shared co-authors 0
Institute of Experimental Medicine and Systems Biology, RWTH Aachen University
Career Start Year 2016
Number of shared co-authors 0
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2015
Number of shared co-authors 0
Technische Universitat Braunschweig, Helmholtz Centre for Infection Research
Career Start Year 2013
Number of shared co-authors 0
McGill University
Career Start Year 2013
Number of shared co-authors 2
Royal Institute of Technology Science for Life Laboratory Stockholm Sweden.
Career Start Year 2012
Number of shared co-authors 0
Harvard Medical School
Career Start Year 2009
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2008
Number of shared co-authors 0
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Duke University
Career Start Year 2007
Number of shared co-authors 7
Research Institute of Molecular Pathology
Career Start Year 2007
Number of shared co-authors 0
Korea Institute of Oriental Medicine
Career Start Year 2006
Number of shared co-authors 0
H. Lee. Moffitt Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Joslin Diabetes Center, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 0
Jilin University
Career Start Year 2005
Number of shared co-authors 0
University of Southern California
Career Start Year 2004
Number of shared co-authors 1
University of California berkeley
Career Start Year 2002
Number of shared co-authors 0
Ben-Gurion University of the Negev
Career Start Year 2002
Number of shared co-authors 0
Institut Necker-Enfants Malades (INEM)
Career Start Year 2002
Number of shared co-authors 0
Massachusetts Institute of Technology
Career Start Year 2002
Number of shared co-authors 1
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Career Start Year 2000
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1999
Number of shared co-authors 0
The Wistar Institute
Career Start Year 1999
Number of shared co-authors 0
Robert Wood Johnson Medical School
Career Start Year 1998
Number of shared co-authors 3
Cellworks Group Inc.
Career Start Year 1994
Number of shared co-authors 0
Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology
Career Start Year 1990
Number of shared co-authors 7
University of California San Diego
Career Start Year 1988
Number of shared co-authors 3
Inc. Research Triangle Park
Career Start Year 1987
Number of shared co-authors 0
Karolinska Institutet
Career Start Year 1980
Number of shared co-authors 0
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 0

Collaborators

University of Toronto
Co-authored papers 10
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 4
Princess Margaret Cancer Centre, Ontario Cancer Institute
Co-authored papers 3
Van Andel Institute
Co-authored papers 3
University of California los angeles
Co-authored papers 3
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 2
Princess Margaret Cancer Centre
Co-authored papers 2
Princess Margaret Cancer Centre
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
University Health Network, University of Toronto
Co-authored papers 2
University of Toronto
Co-authored papers 2
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network, University Ave.
Co-authored papers 2
Montreal Heart Institute Montreal Quebec Canada.
Co-authored papers 2
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Co-authored papers 2
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
University Health Network
Co-authored papers 2
Ontario Institute for Cancer Research
Co-authored papers 1
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Princess Margaret Cancer Centre
Co-authored papers 1
Princess Margaret Cancer Centre
Co-authored papers 1
College Street, University of Toronto
Co-authored papers 1
Institute of Cancer Research
Co-authored papers 1
Sunnybrook Research Institute, University of Toronto
Co-authored papers 1
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 1
McGill University
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1